What We Do

Innovative trial designs. We consistently break the mold on how trials are designed and conducted to accelerate discoveries that benefit patients.
Launch trials faster. We streamlined the process to launch multi-center clinical trials to save time and money.
Tackle tough cancers. We explore novel treatments for historically hard-to-treat cancers that include tumors of the brain, pancreas and breast.

Learn from each patient. Each tissue and blood sample is run through a suite of molecular assays to add to our understanding of cancer biology.
Smarter trials. Our first-of-its-kind analysis platform integrates data across our studies and public data to power smarter, science-driven clinical trials.

Meet Our Experts

Ute Dugan, MD, PhD
Chief Medical Officer

Lacey Padrón, PhD
Head of Informatics

Christine (Chris) Spencer, PhD
Associate Director, Informatics

Christopher Perry
Associate Director, Biospecimen Operations

A Study of Novel Immunotherapy Combinations for Metastatic Pancreatic Cancer

A Study of Novel Combination Therapies for Metastatic Prostate Cancer

A Study to Explore Patient Response to Checkpoint Inhibitors in Advanced Melanoma

Pancreatic Cancer: Can a Combination of Immunotherapy and Chemotherapy Defeat It?

Cancer-Fighting T-Cells Engineered Using CRISPR

The Microbiome and Cancer: Can Gut Bacteria Help Immunotherapy Destroy Tumors?

Taking Cancer’s Temperature: Biomarkers for Checkpoint Response in Hot vs. Cold Tumors